Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report)'s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $16.72, but opened at $16.00. Sysmex shares last traded at $16.17, with a volume of 14,584 shares.
Sysmex Stock Performance
The firm has a 50-day moving average of $16.85 and a two-hundred day moving average of $17.95. The company has a quick ratio of 2.30, a current ratio of 2.97 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $10.68 billion, a PE ratio of 30.30 and a beta of 1.14.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.04). The company had revenue of $958.89 million for the quarter, compared to analysts' expectations of $991.22 million. Sysmex had a net margin of 10.56% and a return on equity of 11.81%. Research analysts anticipate that Sysmex Corporation ADR will post 0.57 EPS for the current year.
About Sysmex
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Featured Stories
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access